Zydus Cadila and Lilly Enter US$300 M Research Pact
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 3 (Table of Contents)
Published: 31 Mar-2009
DOI: 10.3833/pdr.v2009.i3.1085 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Zydus Cadila entered into an agreement with Eli Lilly & Co to discover and develop new drugs focused on treating cardiovascular diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.
Login Problems
RSS